Hydrobromure de fatosulfate, > = 98% ( HPLC), poudre

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Fatostatin hydrobromide has been used:to study its anti-cancer activity and effects on mitotic microtubule spindleto study its effects on stomatal developmentto prevent SREBP cleavage-activating protein (SCAP)-mediated escort of sterol regulatory element-binding proteins (SREBPs)

Biochem/physiol Actions

Fatostatin hydrobromide is an SREBP inhibitor. Fatostatin hydrobromide inhibits fat production and lowers glucose levels in mice by inhibiting SREBP (Sterol Regulatory Element Binding Proteins).

General description

Fatostatin is a non-sterol diarylthiazole derivative. It prevents insulin-induced adipogenesis and lowers the amounts of fatty acid, triglyceride and low-density lipoprotein. Fatostatin has anti tumor and antimitotic properties.

Packaging

5, 25 mg in glass bottle